Comparison of various lazaroid compounds for protection against ischemic liver injury

Transplantation Proceedings

Volumn 29, Issue 1-2, 1997, Pages 1333-1334

  Ishizaki, N ^a   Zhu, Y ^a   Zhang, S ^a   Nemoto, A ^a   Kobayashi, Y ^a   Subbotin, V M ^a   Lee, R G ^a   Starzl, T E ^a   Todo, S ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

21 [4 [2,6 BIS(1 PYRROLIDINYL) 4 PYRIMIDINYL] 1 PIPERAZINYL]PREGNA 1,4,9(11) TRIENE 3,20 DIONE; 21 [4 [5,6 BIS(DIETHYLAMINO) 2 PYRIDYL] 1 PIPERAZINYL] 16ALPHA METHYLPREGNA 1,4,9(11) TRIENE 3,20 DIONE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; TIRILAZAD;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARACHIDONIC ACID METABOLISM; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONFERENCE PAPER; DOG; DOWN REGULATION; DRUG EFFECT; DRUG EFFICACY; GRAFT PRESERVATION; GRAFT SURVIVAL; INTRAVENOUS DRUG ADMINISTRATION; KUPFFER CELL; LIPID PEROXIDATION; LIVER ISCHEMIA; LIVER PROTECTION; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; ASPARTATE AMINOTRANSFERASES; DOGS; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; ISCHEMIA; LIVER; ORGAN PRESERVATION; PREGNATRIENES; REPERFUSION INJURY;

EID: 0030938742     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(96)00581-7     Document Type: Conference Paper

References (6)

1. Broughler JM, Chase RL, Neff GL, et al: J Pharmacol Exp Ther 244:423, 1988
2. Currin RT, Reinstein LJ, Lichtman RG, et al: Transplant Proc 25:1631, 1993
3. Shenkar R, Abraham E: Crit Care Med 23:132, 1995
4. Todo S, Hamada N, Zhu Y, et al: Transplantation 61:189, 1996
5. Braughler JM, Pregenzer JF, Chase RL: J Biol Chem 262: 10438, 1987
6. Fleckenstein AE, Smith SL, Linseman KL, et al: Circ Shock 35:223, 1991